Ryan has been working behind the scenes for months now, helping to establish The Patient Company, and further develop SimPull. Ryan brings a wealth of knowledge and experience to the table, through his commitment and focus to drive value for clinicians and patients Ryan has quickly become a pivotal part of the team. We’re excited to announce that today he is formally joining The Patient Company as our new COO.
Ryan has broadly diverse innovation ecosystem experience working across markets on “big ideas” to improve the private and public sector partnerships. He has high-tech experience working with progressive technology company ventures backed by Palo Alto Networks, Intel Capital, Blackstone Group, ClearSky and General Catalyst companies. His continued focus is on advancing strategic capabilities working with state-of-the-art technology innovation centers and programs like CWIX eXercise (CWIX) program, a DoD NATO managed innovation effort. Ryan has been dedicated to develop interoperable technology innovations that support solving critical market gaps in technology and healthcare.
He has also served as a member of the Michigan Healthcare Cybersecurity Council (MiHCC) where he Co-Chaired the MiHCC Training and Awareness Sub-Committee during its start-up. Ryan received a bachelors degree in Business Administration and Spanish from Hope College.
For the Patient Company Ryan’s focus is on diversifying pathways that deepen the value proposition of the SimPull device and the Company’s overall operations. To be able to generate market traction and revenue growth. Ryan is excited to be part of the Company’s long-term vision, saying, “SimPull exemplifies today’s needs to lead effective health reform by example: Improved quality, workflow and safety while reducing risk for clinicians and patients. I’m looking forward to joining that journey here at the Patient Company.”